Under current law, the opioid antagonist bulk purchase fund (fund)
allows the department of public health and environment (department) to bulk purchase opioid antagonists and distribute them to eligible entities.
In contracting for the bulk purchasing and distribution of opioid
antagonists, the bill requires the department to contract with an opioid antagonist medication distributor. However, the bill prohibits the department from contracting with an opioid antagonist medication distributor if the distributor:
•
Was found liable for the manufacture or distribution of an opioid that resulted in an opioid-related overdose;
•
Is or was a liable party to a settlement agreement for the manufacture or distribution of an opioid that resulted in an opioid-related overdose; or
•
Is or was liable for a fine or penalty levied by a governmental entity for the manufacture or distribution of an opioid that resulted in an opioid-related overdose.
The bill requires the department to implement a competitive
selection process for the bulk purchase of opioid antagonists.
The bill declares any contract or agreement that does not comply
with the contracting requirements of the bill is void and unenforceable.
